Clinical Trials
7
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
- Conditions
- Hyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- CardioKine Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT01056848
- Locations
- πΊπΈ
Torrance Clinical Research, Lomita, California, United States
πΊπΈInnovative Research of West Florida, Clearewater, Florida, United States
πΊπΈFleming Island Center for Clinical Research, Fleming Island, Florida, United States
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- CardioKine Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT01055912
- Locations
- πΊπΈ
Mobile Heart Specialists, PC, Mobile, Alabama, United States
πΊπΈPhoenix Clinical, Phoenix, Arizona, United States
πΊπΈNea Clinic, Jonesboro, Arkansas, United States
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- CardioKine Inc.
- Target Recruit Count
- 206
- Registration Number
- NCT00876798
- Locations
- πΊπΈ
Birmingham Nursing and Rehabilitation East, Birmingham, Alabama, United States
πΊπΈHealthscan Research, LLC, Montgomery, Alabama, United States
πΊπΈPsyPharma Clinical Research, Inc., Phoenix, Arizona, United States
International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2010-11-23
- Lead Sponsor
- CardioKine Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00876876
A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- CardioKine Inc.
- Target Recruit Count
- 298
- Registration Number
- NCT00675701
- Locations
- πΊπΈ
Research Site 1, Austin, Texas, United States
- Prev
- 1
- 2
- Next